Skip to main content
. Author manuscript; available in PMC: 2021 Jan 1.
Published in final edited form as: Endocr Relat Cancer. 2020 Jan;27(1):1–9. doi: 10.1530/ERC-19-0370

Table 2.

Univariate associations of sCD105 with pre-surgical and pathologic covariants in PCa patients with a pre-surgical PSA ≤ 10.

Variable N sCD105 (ng/ml) Median (IQR) or Spearman CC P value
Pre-surgery PSA (ng/mL) 181 −0.181 0.015
Age at surgery (Years) 181 −0.206 0.006
Total Gleason
 5–6 60 6.07 (4.17 – 7.95) 0.077
 7 114 5.31 (3.44 – 7.10)
 8–9 7 3.17 (1.96 – 6.80)
Surgical margin
 Yes 42 6.42 (4.88 – 7.95) 0.037
 No 139 5.31 (3.24 – 7.10)
T stage
 T2 142 5.68 (3.84 – 7.42) 0.066
 T3 39 4.97 (3.08 – 6.78)

P-value is calculated by Kruskal-Wallis test, Wilcoxon rank-sum test, or Spearman rank correlation as appropriate.

Abbreviation: IQR, interquartile range; CC, correlation coefficient.